Malaria on the Guiana Shield: a review of the situation in French Guiana, Mem Inst Oswaldo Cruz, vol.109, pp.525-558, 2014. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01109689
Prevalence of Plasmodium spp. in illegal gold miners in French Guiana in 2015: a hidden but critical malaria reservoir, Malar J, vol.2016, issue.15, p.315, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01346800
Predictors of antimalarial self-medication in illegal gold miners in French Guiana: a pathway towards artemisinin resistance, J Antimicrob Chemother, vol.73, pp.231-240, 2018. ,
URL : https://hal.archives-ouvertes.fr/inserm-01622957
Malaria hyperendemicity and risk for artemisinin resistance among illegal gold miners, Emerg Infect Dis, vol.22, pp.903-909, 2016. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01305106
Situation épidémiologique du paludisme en Guyane, 2017. ,
Evolution de la situation épidémiologique du paludisme en Guyane de, Bulletin de veille sanitaire CIRE Antilles-Guyane, vol.1, issue.2, pp.5-11, 2005. ,
, Geneva: World Health Organization, 2017.
Relapses of Plasmodium vivax infection result from clonal hypnozoites activated at predetermined intervals, J Infect Dis, vol.195, pp.934-975, 2007. ,
Statistical methods to derive efficacy estimates of anti-malarials for uncomplicated Plasmodium falciparum malaria: pitfalls and challenges, Malar J, vol.16, p.430, 2017. ,
Critical evaluation of molecular monitoring in malaria drug efficacy trials and pitfalls of length-polymorphic markers, Antimicrob Agents Chemother, vol.61, pp.1500-1516, 2017. ,
Determination of the Plasmodium vivax relapse pattern in Camopi, French Guiana, Malar J, vol.8, p.278, 2009. ,
URL : https://hal.archives-ouvertes.fr/inserm-00663913
G6PD deficiency working group. Glucose-6-phosphate dehydrogenase deficiency and antimalarial drug development, Am J Trop Med Hyg, vol.77, pp.779-89, 2007. ,
The burden of Plasmodium vivax relapses in an Amerindian village in French Guiana, Malar J, vol.12, p.367, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-00903890
, Guidelines for the treatment of malaria, 2015.
Primaquine: report from CDC expert meeting on malaria chemoprophylaxis I, Am J Trop Med Hyg, vol.75, pp.402-417, 2006. ,
UK malaria treatment guidelines, J Infect, vol.54, pp.111-132, 2007. ,
Haut Conseil de la Santé Publique, 2008. ,
Studies on a primaquine-tolerant strain of Plasmodium vivax from Brazil in Aotus and Saimiri monkeys, J Parasitol, vol.83, pp.739-784, 1997. ,
Low response of Colombian strains of Plasmodium vivax to classical antimalarial therapy, Trop Med Parasitol, vol.40, pp.21-24, 1989. ,
Failure of combined chloroquine and high-dose primaquine therapy for Plasmodium vivax malaria acquired in Guyana, South America, Clin Infect Dis, vol.23, pp.1171-1174, 1996. ,
Poor response to primaquine in two cases of Plasmodium vivax malaria from Guatemala, Trop Geogr Med, vol.46, pp.32-35, 1994. ,
Prospective study of Plasmodium vivax malaria recurrence after radical treatment with a chloroquine-primaquine standard regimen in, Antimicrob Agents Chemother, vol.60, pp.4610-4619, 2016. ,
Association of subtherapeutic dosages of a standard drug regimen with failures in preventing relapses of vivax malaria, Am J Trop Med Hyg, vol.65, pp.471-477, 2001. ,
Primaquine for preventing relapse in people with Plasmodium vivax malaria treated with chloroquine, Cochrane Database Syst Rev, p.4389, 2013. ,
Sensitivity of four Central American strains of Plasmodium vivax to primaquine, Am J Trop Med Hyg, vol.23, pp.309-319, 1974. ,
Primaquine therapy for malaria, Clin Infect Dis, vol.39, pp.1336-1381, 2004. ,
Antirelapse efficacy of various primaquine regimens for Plasmodium vivax, Malar Res Treat, p.347018, 2014. ,
17:237 ? fast, convenient online submission ? thorough peer review by experienced researchers in your field ? rapid publication on acceptance ? support for research data, including large and complex data types ? gold Open Access which fosters wider collaboration and increased citations maximum visibility for your research: over 100M website views per year ? At BMC, research is always in progress. Learn more biomedcentral.com/submissions Ready to submit your research ?, Choose BMC and benefit from: primaquine for the treatment of Plasmodium vivax infection in Ethiopia: a randomized controlled trial, vol.14, p.1002299, 2017. ,
Unsupervised primaquine for the treatment of Plasmodium vivax malaria relapses in southern Papua: a hospital-based cohort study, PLoS Med, vol.14, p.1002379, 2017. ,
Efficacy in the treatment of malaria by Plasmodium vivax in Oiapoque, Brazil, on the border with French Guiana: the importance of control over external factors, Malar J, vol.14, p.402, 2015. ,
Primaquine radical cure of Plasmodium vivax: a critical review of the literature, Malar J, vol.11, p.280, 2012. ,
Primaquine resistance in Plasmodium vivax, Am J Trop Med Hyg, vol.55, pp.243-252, 1996. ,